Tonix Pharmaceuticals Holding Corp (TNXP)
NASDAQ · Healthcare
Tonix Pharmaceuticals Holding Corp EBITDA 2023–2025
Tonix Pharmaceuticals Holding Corp annual/quarterly ebitda history and growth rate from 2023 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Tonix Pharmaceuticals Holding Corp ebitda for the quarter ending March 31, 2026 was -41.0 M, a 163.36% increase year-over-year.
- Tonix Pharmaceuticals Holding Corp ebitda for the twelve months ending March 31, 2026 was -117.0 M, a 15.68% decrease year-over-year.
- Tonix Pharmaceuticals Holding Corp annual ebitda for 2025 was -123.8 M, a 7.13% decrease from 2024.
- Tonix Pharmaceuticals Holding Corp annual ebitda for 2024 was -133.3 M, a 16.82% increase from 2023.
- Tonix Pharmaceuticals Holding Corp annual ebitda for 2023 was -114.1 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Tonix Pharmaceuticals Holding Corp EBITDA — FAQ
Tonix Pharmaceuticals Holding Corp (TNXP) ebitda over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TNXP's ebitda history?
The chart and table above show Tonix Pharmaceuticals Holding Corp's ebitda by year and by quarter, including the growth rate.